DJ Abbott Laboratories Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Abbott Laboratories $(ABT)$ advanced 1.41% to $110.47 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.46% to 7,666.60 and the Dow Jones Industrial Average rising 0.56% to 53,061.95.
The stock's rise snapped a two-day losing streak.
Abbott Laboratories closed 19.65% short of its 52-week high of $137.49, which the company reached on September 22nd.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ rose 1.48% to $275.21, Pfizer Inc. $(PFE)$ rose 1.65% to $29.02, and Merck & Co. Inc. (MRK) rose 1.19% to $151.64.
Data source: Dow Jones Market Data, FactSet. Data compiled September 2, 2026.